GGrantIndex
← Search

Phase III Trial of UCB +/- MSCs in Hematologic Cancers

$405,000U01FY2001HLNIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
Phase III Trial of UCB +/- MSCs in Hematologic Cancers · GrantIndex